Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Lymphoma 4Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Extensive Stage Small Cell Lung Cancer 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Brain Neoplasms 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Mycophenolic Acid 25fludarabine phosphate 21Whole-Body Irradiation 21Cyclophosphamide 21Cyclosporine 16Tacrolimus 15Peripheral Blood Stem Cell Transplantation 15Busulfan 14fludarabine 11Cord Blood Stem Cell Transplantation 9Methotrexate 8Melphalan 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8Antilymphocyte Serum 8Filgrastim 7Thiotepa 6Etoposide 6sargramostim 4merphos 4Radiotherapy 4Drug Therapy 4Cyclosporins 4Azacitidine 4thymoglobulin 3Vorinostat 3Sirolimus 3Lenalidomide 3Idarubicin 3tipifarnib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anemia, Refractory, with Excess of Blasts × Podophyllotoxin × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡